Aug 21 2012
Modern Negative Pressure Wound Therapy (NPWT) has been in practice since the late 1970's when plastic surgeon Dr. Paul Svedman began treating patients. It is estimated that over half a million patients in the United States receive NPWT every year, but that millions more would benefit from the therapy if it were more accessible. New treatment options are critical to continue advancement of the field to save patients with chronic suffering of open wounds. An elite group of surgeons and ITI's executive team met in a forum to discuss the future of NPWT and how the needs of patients in various areas of wound care might be optimized. Mr. Richard Vogel, CEO of ITI, (ITImedical.com), stated "It is imperative that we work in concert with surgeons specialized in the field of NPWT, as there is much unmet need and patients could greatly benefit from further advances in this technology." The forum focused on scientifically advanced topics across wound care settings and across surgical disciplines. The group concluded that more clinical research will be required to further the discussions shared within this forum.
Dr. Michael Kulick, a San Francisco plastic surgeon, stated that "To have this type of medical forum that combines ideas across several surgical specialties was unique and much more forward thinking than what has occurred in the past. This provided us the venue for scientific exchange to further NPWT in our medical practices."
This was the first of many scientific forums that ITI will be supporting as part of its continuing effort to advance the state-of-the-art of NPWT.